Athens Research/Cambio - Excellence in Molecular Biology/250 tests/11-8250

价格
面议
货号:11-8250
浏览量:127
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cell culture contamination control

Cell culture contamination control: Detection

Detection and identification of Mycoplasma

  • Catalogue
  • Description
  • Protocols
  • References
  • Applications & Benefits

Venor®GeM OneStep for conventional, endpoint PCR

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Minerva Biolabs

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
11-8025Venor®GeM OneStep25 tests£134.00QuantityAdd to Order
11-8050Venor®GeM OneStep50 tests£246.00QuantityAdd to Order
11-8100Venor®GeM OneStep100 tests£431.00QuantityAdd to Order
11-8250Venor®GeM OneStep250 tests£916.00QuantityAdd to Order

Venor®GeM OneStep for conventional, endpoint PCR

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Minerva Biolabs

Venor®GeM OneStep

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Type of PCRFor conventional, endpoint PCR

Scope of ApplicationApplicable in research and industry for direct testing of cell cultures and biologicals. Intended for research use only. Not recommended for clinical diagnostics or testing of human samples.

Kit ComponentsPrimer sets, nucleotides, internal amplification control and polymerase at optimized concentrations lyophilized in one tube Rehydration bufferLyophilized positive controlTris/EDTA bufferPackage SizesPrimer sets and nucleotides are prepared in aliquots of 25 tests. Cat. No. 11-8025 25 Tests Cat. No. 11-8050 50 Tests Cat. No. 11-8100 100 Tests Cat. No. 11-8250 250 TestsResult evaluation

Gel electrophoresis at endpoint of PCRRequired ConsumablesAgarose gels and DNA stainsPCR reaction tubesRequired lab devicesGel electrophoresis and documentation system / Regular PCR cyclerPipetting equipmentTube centrifugeShelf Life and StorageVenor®GeM OneStep components are maintainable at2 to8 °C for at least 6 months. After rehydratisation the reagents must be stored at -18 °C.

EP 2.6.7 complianceNo

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor®GeM OneStep for conventional, endpoint PCR

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Minerva Biolabs

Venor®GeMOneStep protocol

Quick visual protocol

Please note: all protocols off site are the responsibility of the products supplier

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor®GeM OneStep for conventional, endpoint PCR

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Minerva Biolabs

For a list of references please click here

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor®GeM OneStep for conventional, endpoint PCR

Venor®GeM OneStep is a complete kit which includes all reagents required for PCR. Primer, nucleotides, polymerase and the internal amplification control are provided ready-to-use in a lyophilized reaction mix. The included rehydration buffer is added to the mix, aliquots made according to the sample number, sample or Positive Control DNA added and the setup is ready for PCR.

Minerva Biolabs

Applicable in research and industry for direct testing of cell cultures and biologicals. Intended for research use only. Not recommended for clinical diagnostics or testing of human samples.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.